PHARMACOKINETICS AND PHARMACODYNAMICS OF A NOVEL ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (HOE 498) IN HEALTHY-SUBJECTS

被引：76

作者：

WITTE, PU

IRMISCH, R

HAJDU, P

METZGER, H

机构：

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 27卷 / 05期

关键词：

D O I：

10.1007/BF00556895

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：577 / 581

页数：5

共 17 条

[1]

BECKER RHA, 1984, ARZNEIMITTELFORSCH

[2] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].

BIOLLAZ, J ;

BURNIER, M ;

TURINI, GA ;

BRUNNER, DB ;

PORCHET, M ;

GOMEZ, HJ ;

JONES, KH ;

FERBER, F ;

ABRAMS, WB ;

GAVRAS, H ;

BRUNNER, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670

[3] ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].

BIOLLAZ, J ;

SCHELLING, JL ;

COMBES, BJD ;

BRUNNER, DB ;

DESPONDS, G ;

BRUNNER, HR ;

ULM, EH ;

HICHENS, M ;

GOMEZ, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368

[4] EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].

BRUNNER, DB ;

DESPONDS, G ;

BIOLLAZ, J ;

KELLER, I ;

FERBER, F ;

GAVRAS, H ;

BRUNNER, HR ;

SCHELLING, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467

[5]

BUNNING P, 1984, ARZNEIMITTELFORSCH

[6]

FELDER K, 1984, ARZNEIMITTELFORSCH

[7] CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CAPTOPRIL [J].

FERGUSON, RK ;

VLASSES, PH .

AMERICAN HEART JOURNAL, 1981, 101 (05) :650-656

[8]

FERGUSON RK, 1977, LANCET, V1, P775

[9]

HAJDU P, 1984, ARZNEIMITTELFORSCH

[10]

KELMAN AW, 1983, BRIT J CLIN PHARMACO, V15, P506, DOI 10.1111/j.1365-2125.1983.tb01542.x

← 1 2 →